The present invention is directed to a compound represented by the following structural formula: or a pharmaceutically acceptable salt thereof. Pharmaceutical composition comprising a compound represented by Structural Formula (I) and method of use of these compound for inhibiting BACE activity in a subject in need of such treatment are also described.
本发明涉及以下结构式所表示的化合物或其药学上可接受的盐。还描述了包含由结构式(I)所表示的化合物的药物组合物和使用这些化合物抑制需要此类治疗的受体中的
BACE活性的方法。